Managing Partner at Unicorn Capital Partners since April 2023. Prior to taking the position, she worked as Deputy Executive Director of the NTI (National Technological Initiative) Venture Fund (2022-2023), and previously served as Executive Director of the private venture fund Primer Capital (2016-2022).
Elizaveta has over 10 years of experience in launching and managing public and private venture funds, leading and supporting biopharmaceutical projects, as well as developing partnerships with scientific, commercial and state institutions.
Elizaveta made multiple presentations at scientific and industrial conferences,and co-authored several patents.
She was a member of the Board of Directors of OncoAtlas and Botkin.AI, and the Supervisory Board of ACTICOR BIOTECH (Series A, IPO Euronext).
In 2002 Elizaveta graduated from the Faculty of Mechanics and Mathematics of Lomonosov Moscow State University, then in 2007 she graduated from the Faculty of Biology of Lomonosov Moscow State University.